Skurup, Sweden

Ake R Lindahl

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 201(Granted Patents)


Company Filing History:


Years Active: 1985-1990

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ake R. Lindahl: Innovator in Pharmaceutical Delivery Systems

Introduction

Ake R. Lindahl is a prominent inventor based in Skurup, Sweden, known for his innovative contributions to the field of pharmaceutical technology. With a total of four patents to his name, Lindahl has made significant strides in the development of sustained-release drug delivery systems.

Latest Patents

One of Lindahl's latest patents focuses on the creation of micro-capsules specifically designed for membrane-coated sustained-release tablets. This pharmaceutical advancement entails a drug-containing tablet enclosed in a water-insoluble coating or membrane. Composed of a terpolymer that includes polyvinylchloride, polyvinylacetate, and polyvinylalcohol, along with a water-soluble pore-creating substance, this invention demonstrates a controlled dissolution rate in gastrointestinal fluids. The design ensures a consistent release of medication, thus optimizing therapeutic effectiveness.

Career Highlights

Ake R. Lindahl has worked with notable companies such as Ab Ferrosan and Biogram AB, where he applied his expertise in pharmaceutical sciences. His inventions have contributed to advancements in drug delivery systems, which play a crucial role in improving patient care and treatment adherence.

Collaborations

Throughout his career, Lindahl has collaborated with esteemed colleagues including Stig A. Erlandsson and Bo M. Ekman. These collaborations have fostered an environment conducive to innovative research and the progression of pharmaceutical technologies.

Conclusion

In conclusion, Ake R. Lindahl stands out as a distinguished inventor in the realm of pharmaceutical innovations. His commitment to developing sustained-release mechanisms has the potential to greatly enhance treatment outcomes for patients. With a robust patent portfolio and a history of meaningful collaborations, Lindahl continues to influence the future of drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…